Literature DB >> 19388930

Identification of a novel epitope derived from CML66 that is recognized by anti-leukaemia cytotoxic T lymphocytes.

Koichiro Suemori, Hiroshi Fujiwara, Toshiki Ochi, Taichi Azuma, Jun Yamanouchi, Hiroshi Narumi, Yoshihiro Yakushijin, Takaaki Hato, Masaki Yasukawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19388930     DOI： 10.1111/j.1365-2141.2009.07695.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer.

Authors:  Bin Han; Yuan-Yuan Zhang; Ke Xu; Yang Bai; Li-Hong Wan; Shi-Kun Miao; Ke-Xian Zhang; Hong-Wei Zhang; Yin Liu; Li-Ming Zhou
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

2.  NudCD1 affects renal cell carcinoma through regulating LIS1/Dynein signaling pathway.

Authors:  Hongchao He; Jun Dai; Xiaojing Wang; Xiaoqiang Qian; Juping Zhao; Haofei Wang; Danfeng Xu
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

3.  Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion.

Authors:  Wandi Zhang; Jaewon Choi; Wanyong Zeng; Shelby A Rogers; Edwin P Alyea; James G Rheinwald; Christine M Canning; Vladimir Brusic; Tetsuro Sasada; Ellis L Reinherz; Jerome Ritz; Robert J Soiffer; Catherine J Wu
Journal:  Clin Cancer Res       Date:  2010-05-11       Impact factor: 12.531
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.